Login
← Go Back
Syngene International
SYNGENE · Pharma > Pharmaceuticals & Drugs · Chairman: Kiran Mazumdar Shaw · MD: Jonathan Hunt · Listing date: Aug. 11, 2015 · Employees: 5437 · Bangalore · http://www.syngeneintl.com
Stock Price vs Company Growth
1d
5.2%
1w
10.5%
1m
5.9%
3m
30.7%
6m
32.2%
1y
40.3%
5y
5.8%
10y
9.5%
all
10.3%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 435 5.2%
380
629
Company Overview
Sales
3,720 Cr
Growth: 5.8%
Profit after Tax
352 Cr
Growth: -24.8%
Mid Cap
17,516 Cr
P/E: 49.7x
Industry P/E: 28.0x
Fundamentals
Sales (Cr) ₹ 3,720
Growth 5.8%
EBITDA 25.8%
P/S 4.7x
Dividend 0.2%
P/E 49.7x
Book Value ₹ 122
PEG Ratio 8.4x
ROE 7.3%
P/B 3.5x
Shareholding Pattern
Institutions
Government Pension Fund Global
1.14 %
Uti-Mid Cap Fund
1.03 %
Qualified Institutional Buyer
0.15 %
Promoters
Biocon Limited
70.1 %
Biocon Limited Employee Welfare Trust (Murali Krishnan K N And Amitava Saha)
0.32 %
Yamini R Mazumdar
0.01 %
Others
Increase    Decrease    No change
Company Profile Detailed
The company is engaged in providing contract research and manufacturing services from lead generation to clinical supplies to pharmaceutical and biotechnology companies worldwide.
Belongs to (32 Indices) view more
Investors (435)
mahesh.g...
k.senthi...
ajit.man...
Followers (15)
yogesh
nitin2
keerthi